Literature DB >> 26742502

Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome.

Elisabeth E Mlynarski1, Michael Xie2, Deanne Taylor2, Molly B Sheridan1, Tingwei Guo3, Silvia E Racedo3, Donna M McDonald-McGinn1,4, Eva W C Chow5, Jacob Vorstman6, Ann Swillen7, Koen Devriendt7, Jeroen Breckpot7, Maria Cristina Digilio8, Bruno Marino9, Bruno Dallapiccola8, Nicole Philip10, Tony J Simon11, Amy E Roberts12, Małgorzata Piotrowicz13, Carrie E Bearden14, Stephan Eliez15, Doron Gothelf16,17, Karlene Coleman18, Wendy R Kates19, Marcella Devoto1,4,20,21, Elaine Zackai1,4, Damian Heine-Suñer22, Elizabeth Goldmuntz4,23, Anne S Bassett5, Bernice E Morrow3, Beverly S Emanuel24,25.   

Abstract

The 22q11.2 deletion syndrome (22q11DS; velocardiofacial/DiGeorge syndrome; VCFS/DGS; MIM #192430; 188400) is the most common microdeletion syndrome. The phenotypic presentation of 22q11DS is highly variable; approximately 60-75 % of 22q11DS patients have been reported to have a congenital heart defect (CHD), mostly of the conotruncal type, and/or aortic arch defect. The etiology of the cardiac phenotypic variability is not currently known for the majority of patients. We hypothesized that rare copy number variants (CNVs) outside the 22q11.2 deleted region may modify the risk of being born with a CHD in this sensitized population. Rare CNV analysis was performed using Affymetrix SNP Array 6.0 data from 946 22q11DS subjects with CHDs (n = 607) or with normal cardiac anatomy (n = 339). Although there was no significant difference in the overall burden of rare CNVs, an overabundance of CNVs affecting cardiac-related genes was detected in 22q11DS individuals with CHDs. When the rare CNVs were examined with regard to gene interactions, specific cardiac networks, such as Wnt signaling, appear to be overrepresented in 22q11DS CHD cases but not 22q11DS controls with a normal heart. Collectively, these data suggest that CNVs outside the 22q11.2 region may contain genes that modify risk for CHDs in some 22q11DS patients.

Entities:  

Mesh:

Year:  2016        PMID: 26742502      PMCID: PMC4896312          DOI: 10.1007/s00439-015-1623-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  51 in total

1.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data.

Authors:  Kai Wang; Mingyao Li; Dexter Hadley; Rui Liu; Joseph Glessner; Struan F A Grant; Hakon Hakonarson; Maja Bucan
Journal:  Genome Res       Date:  2007-10-05       Impact factor: 9.043

Review 2.  Developmental genetics of the heart.

Authors:  J Burn; J Goodship
Journal:  Curr Opin Genet Dev       Date:  1996-06       Impact factor: 5.578

3.  Complex congenital heart disease in unaffected relatives of adults with 22q11.2 deletion syndrome.

Authors:  Jodi-Ann M Swaby; Candice K Silversides; Sean C Bekeschus; Sara Piran; Erwin N Oechslin; Eva W C Chow; Anne S Bassett
Journal:  Am J Cardiol       Date:  2011-02-01       Impact factor: 2.778

Review 4.  A copy number variation map of the human genome.

Authors:  Mehdi Zarrei; Jeffrey R MacDonald; Daniele Merico; Stephen W Scherer
Journal:  Nat Rev Genet       Date:  2015-02-03       Impact factor: 53.242

5.  Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis.

Authors:  T H Shaikh; H Kurahashi; S C Saitta; A M O'Hare; P Hu; B A Roe; D A Driscoll; D M McDonald-McGinn; E H Zackai; M L Budarf; B S Emanuel
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

6.  De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.

Authors:  Steven C Greenway; Alexandre C Pereira; Jennifer C Lin; Steven R DePalma; Samuel J Israel; Sonia M Mesquita; Emel Ergul; Jessie H Conta; Joshua M Korn; Steven A McCarroll; Joshua M Gorham; Stacey Gabriel; David M Altshuler; Maria de Lourdes Quintanilla-Dieck; Maria Alexandra Artunduaga; Roland D Eavey; Robert M Plenge; Nancy A Shadick; Michael E Weinblatt; Philip L De Jager; David A Hafler; Roger E Breitbart; Jonathan G Seidman; Christine E Seidman
Journal:  Nat Genet       Date:  2009-07-13       Impact factor: 38.330

7.  Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield.

Authors:  Juan Geng; Jonathan Picker; Zhaojing Zheng; Xiaoqing Zhang; Jian Wang; Fuki Hisama; David W Brown; Mary P Mullen; David Harris; Joan Stoler; Ann Seman; David T Miller; Qihua Fu; Amy E Roberts; Yiping Shen
Journal:  BMC Genomics       Date:  2014-12-17       Impact factor: 3.969

8.  Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways.

Authors:  Candice K Silversides; Anath C Lionel; Gregory Costain; Daniele Merico; Ohsuke Migita; Ben Liu; Tracy Yuen; Jessica Rickaby; Bhooma Thiruvahindrapuram; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  PLoS Genet       Date:  2012-08-09       Impact factor: 5.917

9.  Rare de novo copy number variants in patients with congenital pulmonary atresia.

Authors:  Li Xie; Jin-Lan Chen; Wei-Zhi Zhang; Shou-Zheng Wang; Tian-Li Zhao; Can Huang; Jian Wang; Jin-Fu Yang; Yi-Feng Yang; Zhi-Ping Tan
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

10.  Refining analyses of copy number variation identifies specific genes associated with developmental delay.

Authors:  Bradley P Coe; Kali Witherspoon; Jill A Rosenfeld; Bregje W M van Bon; Anneke T Vulto-van Silfhout; Paolo Bosco; Kathryn L Friend; Carl Baker; Serafino Buono; Lisenka E L M Vissers; Janneke H Schuurs-Hoeijmakers; Alex Hoischen; Rolph Pfundt; Nik Krumm; Gemma L Carvill; Deana Li; David Amaral; Natasha Brown; Paul J Lockhart; Ingrid E Scheffer; Antonino Alberti; Marie Shaw; Rosa Pettinato; Raymond Tervo; Nicole de Leeuw; Margot R F Reijnders; Beth S Torchia; Hilde Peeters; Brian J O'Roak; Marco Fichera; Jayne Y Hehir-Kwa; Jay Shendure; Heather C Mefford; Eric Haan; Jozef Gécz; Bert B A de Vries; Corrado Romano; Evan E Eichler
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more
  19 in total

Review 1.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

2.  Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.

Authors:  Anne S Bassett; Chelsea Lowther; Daniele Merico; Gregory Costain; Eva W C Chow; Therese van Amelsvoort; Donna McDonald-McGinn; Raquel E Gur; Ann Swillen; Marianne Van den Bree; Kieran Murphy; Doron Gothelf; Carrie E Bearden; Stephan Eliez; Wendy Kates; Nicole Philip; Vandana Sashi; Linda Campbell; Jacob Vorstman; Joseph Cubells; Gabriela M Repetto; Tony Simon; Erik Boot; Tracy Heung; Rens Evers; Claudia Vingerhoets; Esther van Duin; Elaine Zackai; Elfi Vergaelen; Koen Devriendt; Joris R Vermeesch; Michael Owen; Clodagh Murphy; Elena Michaelovosky; Leila Kushan; Maude Schneider; Wanda Fremont; Tiffany Busa; Stephen Hooper; Kathryn McCabe; Sasja Duijff; Karin Isaev; Giovanna Pellecchia; John Wei; Matthew J Gazzellone; Stephen W Scherer; Beverly S Emanuel; Tingwei Guo; Bernice E Morrow; Christian R Marshall
Journal:  Am J Psychiatry       Date:  2017-07-28       Impact factor: 18.112

Review 3.  Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers.

Authors:  Marta Unolt; Paolo Versacci; Silvia Anaclerio; Caterina Lambiase; Giulio Calcagni; Matteo Trezzi; Adriano Carotti; Terrence Blaine Crowley; Elaine H Zackai; Elizabeth Goldmuntz; James William Gaynor; Maria Cristina Digilio; Donna M McDonald-McGinn; Bruno Marino
Journal:  Am J Med Genet A       Date:  2018-04-16       Impact factor: 2.802

Review 4.  Molecular genetics of 22q11.2 deletion syndrome.

Authors:  Bernice E Morrow; Donna M McDonald-McGinn; Beverly S Emanuel; Joris R Vermeesch; Peter J Scambler
Journal:  Am J Med Genet A       Date:  2018-10       Impact factor: 2.802

5.  Association of a functional Claudin-5 variant with schizophrenia in female patients with the 22q11.2 deletion syndrome.

Authors:  Yiran Guo; Larry N Singh; Yuankun Zhu; Raquel E Gur; Adam Resnick; Stewart A Anderson; Jorge I Alvarez
Journal:  Schizophr Res       Date:  2019-10-23       Impact factor: 4.939

6.  The importance of copy number variation in congenital heart disease.

Authors:  Gregory Costain; Candice K Silversides; Anne S Bassett
Journal:  NPJ Genom Med       Date:  2016-09-14       Impact factor: 8.617

7.  Deletion Extents Are Not the Cause of Clinical Variability in 22q11.2 Deletion Syndrome: Does the Interaction between DGCR8 and miRNA-CNVs Play a Major Role?

Authors:  Veronica Bertini; Alessia Azzarà; Annalisa Legitimo; Roberta Milone; Roberta Battini; Rita Consolini; Angelo Valetto
Journal:  Front Genet       Date:  2017-05-01       Impact factor: 4.599

Review 8.  A Path to Implement Precision Child Health Cardiovascular Medicine.

Authors:  Marlin Touma; Brian Reemtsen; Nancy Halnon; Juan Alejos; J Paul Finn; Stanley F Nelson; Yibin Wang
Journal:  Front Cardiovasc Med       Date:  2017-06-01

9.  Partial microduplication in the histone acetyltransferase complex member KANSL1 is associated with congenital heart defects in 22q11.2 microdeletion syndrome patients.

Authors:  Luis E León; Felipe Benavides; Karena Espinoza; Cecilia Vial; Patricia Alvarez; Mirta Palomares; Guillermo Lay-Son; Macarena Miranda; Gabriela M Repetto
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

10.  A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.

Authors:  R E Gur; A S Bassett; D M McDonald-McGinn; C E Bearden; E Chow; B S Emanuel; M Owen; A Swillen; M Van den Bree; J Vermeesch; J A S Vorstman; S Warren; T Lehner; B Morrow
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.